Santen Pharmaceutical Co., Ltd. (4536.T) JPX

1,739.50

+24(+1.40%)

Updated at January 14 03:30PM

Currency In JPY

Valuation

Market Cap494.32B
Enterprise Value435.55B
P/E Ratio18.27
PEG Ratio13.05
Price/Sales Ratio2.02
Price/Book Ratio2.09
Enterprise/Revenue1.92
Enterprise/EBITDA9.05

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.11
Operating Margin0.15

Management Effectiveness

Return On Assets0.08
Return On Equity0.11

Income Statement

Revenue300B
Revenue/Share883.35
Gross Profit171.03B
EBITDA68.83B
Net Income36.25B
Diluted EPS103.68

Balance Sheet

Total Cash66.08B
Total Cash/Share200.27
Total Debt35.63B
Total Debt/Equity0.13
Current Ratio2.65
Book Value Per Share829.19

Price History

52-Week Change11.11
52-Week High1,763
52-Week Low1,310.5
Moving Average 50 Days1,596.18
Moving Average 200 Days1,575.11

Statistics

Average Volume1.01M
Shares Outstanding337.99M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate38
Trailing Annual Dividend Yield2.18
Payout Ratio0.4
Last Split Factor5:1
Last Split DateMarch 27, 2015